Cycad Group

About The Fund

Cycad Group is a venture capital firm that specializes in cultivating growth in companies with enabling solutions, disruptive technologies, and innovative products that hold potential for significant financial returns and market impact. Founded in the year 2000 and headquartered in Santa Barbara, California, they have carved a niche for themselves by primarily directing investments toward the arenas of life sciences, which encompass therapeutic areas, medical devices, diagnostics, and analytical tools. Additionally, their investment reach extends to domains such as energy technologies, and advanced materials and chemical processes. Their strategic approach is grounded in identifying and supporting ventures that demonstrate a clear competitive advantage through their groundbreaking advancements. Cycad Group’s platform is rooted in the belief that diligent and intelligent investment in such disruptive innovators will not only yield considerable economic benefits but will also contribute positively to the broader scope of human and environmental well-being. Their portfolio is reflective of their commitment to foster transformative advancements in the industries they are passionate about, namely Other, BioTech, Material Science, Medical Devices (& Hospital Services), and Life Science. By providing financial resources, strategic guidance, and a vast network, they enable their portfolio companies to achieve critical milestones, scale their operations, and emerge as leaders in their respective fields. Cycad Group has established itself as a strategic partner to entities striving for breakthroughs that redefine industry standards and advance humanity.